跳至主要内容
临床试验/NCT06003036
NCT06003036已完成不适用

Accelerated Neuromodulation of Prefrontal Circuitry During Clozapine Treatment

Deepak K. Sarpal, M.D.2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
2
主要终点
change in activation of the working memory network

研究概览

简要总结

In this study, the investigators will examine whether a type of repetitive transcranial magnetic stimulation called accelerated intermittent theta burst stimulation (iTBS) can augment neurocognition in individuals who receive treatment with clozapine. Following a baseline evaluation and magnetic resonance imaging (MRI), participants will undergo a session of iTBS +MRI and session of sham delivery + MRI. The order for these sessions will be blinded and randomized. The investigators predict that accelerated iTBS will enhance neurocognition relative to sham delivery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • A current Diagnostic and Statistical Manual of Mental Disorders 5 (DSM 5)-defined diagnosis of schizophrenia or schizoaffective disorder
  • age 18-65 years
  • at least 4 months of clozapine treatment
  • history of at least 2 failed antipsychotic trials
  • competency and willingness to sign informed consent
  • A clinically optimized dosage of clozapine, unchanged for at least 1 month, with a minimum of 150 mg/day

排除标准

  • Serious neurologic or medical condition/treatment that impacts the brain
  • a significant risk of suicidal or homicidal behavior
  • cognitive or language limitations, or any other factor that would preclude subjects providing informed consent
  • pregnancy or postpartum (<6 weeks after delivery or miscarriage)
  • history of treatment with electroconvulsive therapy
  • contraindications for magnetic resonance imaging (e.g., a pacemaker)
  • Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders 5 (DSM 5)-verified moderate or severe substance use disorder, including alcohol use disorder
  • seizure disorder or prior history of seizures on clozapine
  • patients taking both bupropion and clozapine
  • prior issues with intermittent theta burst stimulation/transcranial magnetic stimulation administration
  • Concomitant treatment with serotonin and norepinephrine reuptake inhibitors will be examined on a case-by-case basis.

研究组 & 干预措施

iTBS, then Sham

Experimental

干预措施: sham stimulation (Device)

iTBS, then Sham

Experimental

干预措施: transcranial magnetic stimulation (Device)

Sham, then iTBS

Experimental

干预措施: sham stimulation (Device)

Sham, then iTBS

Experimental

干预措施: transcranial magnetic stimulation (Device)

结局指标

主要结局

change in activation of the working memory network

时间窗: 1 hour

Examine whether accelerated intermittent theta burst stimulation (iTBS) is associated with functional magnetic resonance imaging (fMRI)-based changes in activation of the working memory network during AX-continuous performance task engagement

change in brain functional connectivity within the prefrontal cortex

时间窗: 1 hour

Examine changes in left dorsolateral prefrontal cortex-basal forebrain functional connectivity following adjunctive accelerated intermittent theta burst stimulation (iTBS)

次要结局

  • explore change in functional magnetic resonance imaging (fMRI) measures versus plasma n-desmethylclozapine/clozapine ratios(1 month)

研究者

发起方
Deepak K. Sarpal, M.D.
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Deepak K. Sarpal, M.D.

Assistant Professor

University of Pittsburgh

研究点 (2)

Loading locations...

相似试验